-
Cy3 TSA Fluorescence Kit for Spatial Biology
2026-08-25
The Cy3 TSA Fluorescence System Kit brings localized tyramide signal amplification to IHC, ICC, and ISH. This article explains how it complements emerging spatial proteomics by connecting sensitive target validation with cell-type-resolved tissue analysis.
-
dKeap1–Lamin Control of Drosophila Nuclear Architecture
2026-08-25
Carlson and colleagues identify a molecular and genetic interaction between Drosophila Keap1 and the B-type lamin Dm0, linking xenobiotic-response signaling to nuclear lamina organization and heterochromatin distribution. Their findings suggest that dKeap1 can influence developmental phenotypes not only through transcriptional regulation but also by altering higher-order chromatin architecture.
-
mCherry mRNA Workflows for Reliable Red Reporting
2026-08-24
Use Cap 1, 5mCTP, and ψUTP chemistry to build reproducible red-channel controls for localization, delivery benchmarking, and reporter assays. This guide also shows how mCherry mRNA can complement—but not replace—a regulatory NADH/NAD+ biosensor in workflow design.
-
Biomimetic Chromatography for Pulmonary Permeability
2026-08-24
A 2024 Journal of Chromatography A study directly compared immobilised artificial membrane liquid chromatography with liposome electrokinetic capillary chromatography for drug–membrane partitioning and pulmonary permeability assessment. The findings indicate that LEKC more closely models apparent lung permeability, whereas IAM LC offers broader compound coverage, simpler operation, and stronger suitability for automated screening.
-
Targeted EPO mRNA Nanotherapy for Spinal Cord Injury
2026-08-23
A 2026 Materials Today Bio study developed mannose-modified lipid nanoparticles to deliver EPO mRNA to CD206-enriched inflammatory macrophages and microglia in injured spinal cord. In mice, localized EPO production reduced neuroinflammation and ferroptosis-associated damage while improving axonal preservation and motor recovery, supporting targeted mRNA delivery as a strategy for secondary spinal cord injury repair.
-
Disulfide-Aware Surface Biotinylation for Translation
2026-08-22
Surface biotinylation is most powerful when it is interpreted alongside protein folding, trafficking, and extracellular disulfide biology. This thought-leadership guide positions Sulfo-NHS-SS-Biotin as a reversible tool for studying membrane-protein abundance and purification while clarifying what the chemistry can—and cannot—reveal about transporter structure and function.
-
Arachidonic Acid Supplementation and Humoral Immunity
2026-08-22
The reference study identifies dietary arachidonic acid as a potential nutritional adjuvant that accelerates rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic contribution is to connect lymph-node arachidonic acid metabolism with prostaglandin I2, cAMP–PKA signaling, CD86 expression, and activation-induced cytidine deaminase in B cells.
-
Z-DEVD-FMK: Caspase-3 Inhibition in Apoptosis
2026-08-21
Z-DEVD-FMK is a cell-permeable, irreversible caspase-3 inhibitor used to test executioner-caspase involvement in apoptosis assays. Product documentation also describes calpain inhibition and experimental neuroprotection after traumatic brain injury or cerebral ischemia.
-
Estradiol Benzoate: From Binding to Better Assays
2026-08-20
Estradiol Benzoate is an estrogen receptor alpha agonist for dissecting receptor occupancy, signaling, and assay performance. This guide pairs receptor pharmacology with a structure-based screening study to build a more rigorous, orthogonal workflow for hormone receptor research.
-
Cefotaxime for Reproducible Resistance Assays
2026-08-20
Cefotaxime (SKU BA1012) supports controlled antimicrobial resistance research and bacterial infection model workflows where antibiotic handling, isolate variability, and cell-based readouts can compromise interpretation. This scenario-driven guide connects formulation, storage, experimental controls, and recent carbapenemase-transmission evidence to practical laboratory decisions.
-
Pheromone-Driven Neurodegeneration in C. elegans
2026-08-19
Peng et al. show that pheromone exposure during the L1 developmental stage can remodel neural circuitry and accelerate adult neurodegeneration in C. elegans. Their work identifies coordinated ASK–ASI signaling through AIA interneurons, insulin-like signaling, and autophagy inhibition as a mechanistic link between early chemical experience and later proteostasis failure.
-
mCherry mRNA as an LNP Delivery Assay Control
2026-08-19
mCherry mRNA can serve as more than a fluorescent reporter: it is a functional control for evaluating LNP-mediated RNA delivery before costly gene-editing studies. This article explains how Cap 1, modified nucleotides, and poly(A) design support interpretable fluorescent protein expression.
-
SM-102 for Smarter mRNA Delivery
2026-08-18
SM-102 provides a chemically defined ionizable-lipid starting point for mRNA delivery, from vaccine formulation screens to mechanistic cellular assays. Its strongest use is not as a universal winner, but as a reproducible comparator within data-driven lipid nanoparticle optimization.
-
EdU Flow Cytometry Assay Kits (Cy5): Practical Guide
2026-08-18
EdU Flow Cytometry Assay Kits (Cy5) support quantitative measurement of DNA synthesis during S phase without the harsh DNA denaturation used in many BrdU workflows. This guide covers setup, controls, gating, and troubleshooting; the assay should be used to measure labeled DNA synthesis during a defined pulse, not as a standalone proof of total cell proliferation or complete cell-cycle progression.
-
Prevotella copri, IPA Depletion, and Breast Cancer
2026-08-17
The reference study links Prevotella copri enrichment with breast cancer progression through depletion of host indole-3-pyruvic acid, a tryptophan-derived metabolite. Its integrated microbiome, metabolite, animal, and molecular analyses connect reduced IPA availability with UHRF1-mediated suppression of AMPK signaling, while also defining important limits for translation beyond preclinical models.